SIMILAR PATTERNS OF AMINO ACIDS FOR 6BNI_A_ADNA602_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 12as | ASPARAGINESYNTHETASE (Escherichiacoli) |
PF03590(AsnA) | 5 | ARG A 100GLU A 103GLY A 296ARG A 299ILE A 310 | AMP A 332 (-2.9A)AMP A 332 (-3.7A)AMP A 332 (-3.1A)AMP A 332 (-3.8A)None | 0.89A | 6bniA-12asA:23.7 | 6bniA-12asA:13.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 12as | ASPARAGINESYNTHETASE (Escherichiacoli) |
PF03590(AsnA) | 6 | GLU A 103HIS A 110GLU A 248GLY A 296ARG A 299ILE A 310 | AMP A 332 (-3.7A)AMP A 332 (-4.9A)AMP A 332 (-4.0A)AMP A 332 (-3.1A)AMP A 332 (-3.8A)None | 0.73A | 6bniA-12asA:23.7 | 6bniA-12asA:13.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ati | GLYCYL-TRNASYNTHETASE (Thermusthermophilus) |
PF00587(tRNA-synt_2b)PF03129(HGTP_anticodon) | 5 | ARG A 220GLU A 304GLY A 363ARG A 366ILE A 229 | None | 0.92A | 6bniA-1atiA:14.4 | 6bniA-1atiA:10.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ati | GLYCYL-TRNASYNTHETASE (Thermusthermophilus) |
PF00587(tRNA-synt_2b)PF03129(HGTP_anticodon) | 5 | ARG A 220PHE A 235GLY A 363ARG A 366ILE A 229 | None | 0.94A | 6bniA-1atiA:14.4 | 6bniA-1atiA:10.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1b8a | PROTEIN(ASPARTYL-TRNASYNTHETASE) (Thermococcuskodakarensis) |
PF00152(tRNA-synt_2)PF01336(tRNA_anti-codon) | 7 | ARG A 214GLU A 216HIS A 223GLU A 361GLY A 409ARG A 412ILE A 423 | ATP A 500 (-2.7A)ATP A 500 (-3.6A)ATP A 500 (-3.7A) MN A 601 (-2.6A)ATP A 500 (-3.3A)ATP A 500 (-2.5A)None | 0.73A | 6bniA-1b8aA:30.0 | 6bniA-1b8aA:8.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1bbu | PROTEIN (LYSYL-TRNASYNTHETASE) (Escherichiacoli) |
PF00152(tRNA-synt_2)PF01336(tRNA_anti-codon) | 5 | ASN A 260ARG A 262GLU A 264HIS A 270PHE A 274 | NoneLYS A 505 (-4.0A)NoneNoneNone | 0.76A | 6bniA-1bbuA:46.3 | 6bniA-1bbuA:10.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1bbu | PROTEIN (LYSYL-TRNASYNTHETASE) (Escherichiacoli) |
PF00152(tRNA-synt_2)PF01336(tRNA_anti-codon) | 7 | ASN A 260ARG A 262HIS A 270PHE A 274GLY A 477ARG A 480ILE A 491 | NoneLYS A 505 (-4.0A)NoneNoneNoneNoneNone | 0.62A | 6bniA-1bbuA:46.3 | 6bniA-1bbuA:10.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1bbu | PROTEIN (LYSYL-TRNASYNTHETASE) (Escherichiacoli) |
PF00152(tRNA-synt_2)PF01336(tRNA_anti-codon) | 7 | ASN A 260ARG A 262PHE A 274GLU A 421GLY A 477ARG A 480ILE A 491 | NoneLYS A 505 (-4.0A)NoneNoneNoneNoneNone | 0.56A | 6bniA-1bbuA:46.3 | 6bniA-1bbuA:10.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1bbu | PROTEIN (LYSYL-TRNASYNTHETASE) (Escherichiacoli) |
PF00152(tRNA-synt_2)PF01336(tRNA_anti-codon) | 5 | ASN A 260ARG A 262PHE A 274GLY A 477ILE A 495 | NoneLYS A 505 (-4.0A)NoneNoneNone | 1.20A | 6bniA-1bbuA:46.3 | 6bniA-1bbuA:10.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1c0a | ASPARTYL TRNASYNTHETASE (Escherichiacoli) |
PF00152(tRNA-synt_2)PF01336(tRNA_anti-codon)PF02938(GAD) | 6 | ARG A 217PHE A 229GLU A 482GLY A 534ARG A 537ILE A 548 | AMO A 831 (-3.0A)AMO A 831 (-3.2A)AMO A 831 (-3.4A)AMO A 831 (-3.4A)AMO A 831 (-4.0A)None | 0.44A | 6bniA-1c0aA:21.6 | 6bniA-1c0aA:7.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1e1t | LYSYL-TRNASYNTHETASE, HEATINDUCIBLE (Escherichiacoli) |
PF00152(tRNA-synt_2)PF01336(tRNA_anti-codon) | 8 | ARG A 262GLU A 264HIS A 270PHE A 274GLU A 421GLY A 477ARG A 480ILE A 491 | LAD A 601 ( 2.6A)LAD A 601 (-4.0A)POP A 602 (-4.0A)LAD A 601 (-3.4A) MG A 603 (-2.7A)LAD A 601 (-3.4A)POP A 602 ( 2.4A)None | 0.40A | 6bniA-1e1tA:46.9 | 6bniA-1e1tA:11.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1e1t | LYSYL-TRNASYNTHETASE, HEATINDUCIBLE (Escherichiacoli) |
PF00152(tRNA-synt_2)PF01336(tRNA_anti-codon) | 8 | ASN A 260ARG A 262GLU A 264HIS A 270PHE A 274GLY A 477ARG A 480ILE A 491 | NoneLAD A 601 ( 2.6A)LAD A 601 (-4.0A)POP A 602 (-4.0A)LAD A 601 (-3.4A)LAD A 601 (-3.4A)POP A 602 ( 2.4A)None | 0.42A | 6bniA-1e1tA:46.9 | 6bniA-1e1tA:11.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1eov | ASPARTYL-TRNASYNTHETASE (Saccharomycescerevisiae) |
PF00152(tRNA-synt_2)PF01336(tRNA_anti-codon) | 5 | ARG A 325HIS A 334PHE A 338GLY A 528ILE A 542 | None | 1.01A | 6bniA-1eovA:27.7 | 6bniA-1eovA:9.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1evl | THREONYL-TRNASYNTHETASE (Escherichiacoli) |
PF00587(tRNA-synt_2b)PF03129(HGTP_anticodon) | 5 | ARG A 363GLU A 365PHE A 379GLY A 516ARG A 520 | TSB A2002 (-2.7A)TSB A2002 (-3.7A)TSB A2002 (-3.6A)TSB A2002 (-3.3A)TSB A2002 (-3.9A) | 0.66A | 6bniA-1evlA:11.2 | 6bniA-1evlA:12.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ggm | GLYCINE--TRNA LIGASE (Thermusthermophilus) |
PF00587(tRNA-synt_2b)PF03129(HGTP_anticodon) | 6 | ARG A 220GLU A 222PHE A 235GLU A 304GLY A 363ARG A 366 | GAP A1550 ( 2.4A)GAP A1550 (-3.2A)GAP A1550 ( 3.5A)GAP A1550 ( 3.8A)GAP A1550 (-2.7A)GAP A1550 ( 3.4A) | 0.64A | 6bniA-1ggmA:13.7 | 6bniA-1ggmA:10.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1htt | HISTIDYL-TRNASYNTHETASE (Escherichiacoli) |
PF03129(HGTP_anticodon)PF13393(tRNA-synt_His) | 5 | ARG A 113GLU A 115PHE A 125GLY A 308ARG A 311 | AMP A 451 ( 2.3A)AMP A 451 ( 3.7A)AMP A 451 ( 3.5A)AMP A 451 (-3.5A)AMP A 451 ( 3.9A) | 0.63A | 6bniA-1httA:13.5 | 6bniA-1httA:10.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1izc | MACROPHOMATESYNTHASEINTERMOLECULARDIELS-ALDERASE (Macrophomacommelinae) |
PF03328(HpcH_HpaI) | 5 | ASN A 246HIS A 203ALA A 197GLU A 201ILE A 181 | None | 1.15A | 6bniA-1izcA:undetectable | 6bniA-1izcA:13.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1kh2 | ARGININOSUCCINATESYNTHETASE (Thermusthermophilus) |
PF00764(Arginosuc_synth) | 5 | ARG A 92PHE A 125ALA A 115GLY A 114ILE A 111 | ATP A 510 ( 4.1A)ATP A 510 (-3.9A)ATP A 510 (-4.3A)ATP A 510 (-3.1A)None | 0.99A | 6bniA-1kh2A:undetectable | 6bniA-1kh2A:10.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1kug | METALLOPROTEINASE (Protobothropsmucrosquamatus) |
PF01421(Reprolysin) | 5 | ASN A 149GLU A 145HIS A 144GLU A 153ILE A 166 | None CD A 981 ( 4.6A) CD A 981 (-3.5A)NoneNone | 1.13A | 6bniA-1kugA:undetectable | 6bniA-1kugA:15.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1nnh | ASPARAGINYL-TRNASYNTHETASE-RELATEDPEPTIDE (Pyrococcusfuriosus) |
PF00152(tRNA-synt_2) | 8 | ASN A 97ARG A 99GLU A 101HIS A 110PHE A 114GLU A 215GLY A 264ARG A 267 | None | 0.73A | 6bniA-1nnhA:28.1 | 6bniA-1nnhA:14.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1nnh | ASPARAGINYL-TRNASYNTHETASE-RELATEDPEPTIDE (Pyrococcusfuriosus) |
PF00152(tRNA-synt_2) | 8 | ASN A 97ARG A 99GLU A 101HIS A 110PHE A 114GLY A 264ARG A 267ILE A 278 | None | 0.55A | 6bniA-1nnhA:28.1 | 6bniA-1nnhA:14.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1oa1 | HYDROXYLAMINEREDUCTASE (Desulfovibriovulgaris) |
PF03063(Prismane) | 5 | ASN A 74ARG A 79ALA A 68GLY A 65ILE A 84 | None | 1.24A | 6bniA-1oa1A:undetectable | 6bniA-1oa1A:7.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1oi1 | SCML2 PROTEIN (Homo sapiens) |
PF02820(MBT) | 5 | GLU A 37HIS A 34ALA A 227GLY A 228ARG A 231 | None | 1.20A | 6bniA-1oi1A:undetectable | 6bniA-1oi1A:13.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1qf6 | THREONYL-TRNASYNTHETASE (Escherichiacoli) |
PF00587(tRNA-synt_2b)PF02824(TGS)PF03129(HGTP_anticodon)PF07973(tRNA_SAD) | 5 | ARG A 363GLU A 365PHE A 379GLY A 516ARG A 520 | AMP A1002 (-2.7A)AMP A1002 (-3.7A)AMP A1002 (-3.7A)AMP A1002 (-3.0A)AMP A1002 (-3.7A) | 0.71A | 6bniA-1qf6A:13.0 | 6bniA-1qf6A:7.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1rqg | METHIONYL-TRNASYNTHETASE (Pyrococcusabyssi) |
PF08264(Anticodon_1)PF09334(tRNA-synt_1g) | 5 | ASN A 449ARG A 451GLU A 377GLY A 444ILE A 31 | None | 1.08A | 6bniA-1rqgA:undetectable | 6bniA-1rqgA:7.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1vz8 | ORNITHINEACETYL-TRANSFERASE (Streptomycesclavuligerus) |
PF01960(ArgJ) | 5 | GLU A 59ALA A 50GLU A 85GLY A 51ILE A 108 | None | 1.22A | 6bniA-1vz8A:undetectable | 6bniA-1vz8A:9.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1wle | SERYL-TRNASYNTHETASE (Bos taurus) |
PF00587(tRNA-synt_2b) | 5 | ARG A 313GLU A 315PHE A 331ALA A 439GLU A 401 | SRP A 900 (-2.6A)SRP A 900 (-3.5A)SRP A 900 (-4.0A)SRP A 900 (-3.5A)SRP A 900 (-3.6A) | 1.15A | 6bniA-1wleA:10.8 | 6bniA-1wleA:12.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1wle | SERYL-TRNASYNTHETASE (Bos taurus) |
PF00587(tRNA-synt_2b) | 5 | ARG A 313GLU A 315PHE A 331GLU A 401ARG A 442 | SRP A 900 (-2.6A)SRP A 900 (-3.5A)SRP A 900 (-4.0A)SRP A 900 (-3.6A)SRP A 900 ( 4.1A) | 0.71A | 6bniA-1wleA:10.8 | 6bniA-1wleA:12.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1x55 | ASPARAGINYL-TRNASYNTHETASE (Pyrococcushorikoshii) |
PF00152(tRNA-synt_2)PF01336(tRNA_anti-codon) | 7 | ARG A 211HIS A 220PHE A 224GLU A 357GLY A 405ARG A 408ILE A 419 | NSS A3002 (-2.9A)PO4 A3001 ( 4.1A)NSS A3002 (-3.4A) MG A2001 (-2.6A)NSS A3002 (-3.2A)PO4 A3001 ( 3.2A)None | 0.90A | 6bniA-1x55A:31.0 | 6bniA-1x55A:11.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2amc | PHENYLALANYL-TRNASYNTHETASE ALPHACHAIN (Thermusthermophilus) |
PF01409(tRNA-synt_2d) | 5 | GLU A 206HIS A 212PHE A 216GLY A 318ILE A 332 | None | 0.76A | 6bniA-2amcA:5.2 | 6bniA-2amcA:15.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2cja | SERYL-TRNASYNTHETASE (Methanosarcinabarkeri) |
no annotation | 5 | ARG A 336GLU A 338PHE A 351GLU A 432ARG A 468 | ATP A1505 (-2.9A)ATP A1505 (-3.3A)ATP A1505 (-3.4A)ATP A1505 (-2.9A)ATP A1505 (-3.9A) | 0.96A | 6bniA-2cjaA:9.6 | 6bniA-2cjaA:10.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2cja | SERYL-TRNASYNTHETASE (Methanosarcinabarkeri) |
no annotation | 5 | ARG A 336GLU A 338PHE A 351GLY A 465ARG A 468 | ATP A1505 (-2.9A)ATP A1505 (-3.3A)ATP A1505 (-3.4A)ATP A1505 (-3.3A)ATP A1505 (-3.9A) | 0.93A | 6bniA-2cjaA:9.6 | 6bniA-2cjaA:10.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2d3a | GLUTAMINE SYNTHETASE (Zea mays) |
PF00120(Gln-synt_C)PF03951(Gln-synt_N) | 5 | GLU A 129HIS A 249ALA A 309GLU A 297ARG A 332 | MN A1002 ( 2.0A) MN A1002 ( 3.5A)NoneP3S A5001 (-3.4A)P3S A5001 ( 3.1A) | 1.17A | 6bniA-2d3aA:undetectable | 6bniA-2d3aA:12.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2dq3 | SERYL-TRNASYNTHETASE (Aquifexaeolicus) |
PF00587(tRNA-synt_2b)PF02403(Seryl_tRNA_N) | 5 | ARG A 262GLU A 264PHE A 281GLU A 349ARG A 391 | SSA A1001 (-2.8A)SSA A1001 (-3.3A)SSA A1001 (-3.5A)SSA A1001 (-3.1A)SSA A1001 (-3.3A) | 0.68A | 6bniA-2dq3A:4.9 | 6bniA-2dq3A:9.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2i4n | PROLINE-TRNA LIGASE (Rhodopseudomonaspalustris) |
PF00587(tRNA-synt_2b)PF03129(HGTP_anticodon) | 6 | ARG A 140GLU A 142PHE A 155GLU A 282GLY A 319ARG A 322 | 5CA A 439 (-2.8A)5CA A 439 (-3.2A)5CA A 439 (-3.6A)5CA A 439 (-3.7A)5CA A 439 (-3.5A)5CA A 439 (-3.7A) | 0.70A | 6bniA-2i4nA:9.4 | 6bniA-2i4nA:10.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2j3m | PROLYL-TRNASYNTHETASE (Enterococcusfaecalis) |
PF00587(tRNA-synt_2b)PF03129(HGTP_anticodon)PF04073(tRNA_edit) | 6 | ARG A 140GLU A 142PHE A 155GLU A 407GLY A 444ARG A 447 | ATP A 701 ( 2.6A)ATP A 701 (-3.4A)ATP A 701 (-3.5A) MN A1567 (-2.5A)ATP A 701 (-3.3A)ATP A 701 (-2.5A) | 0.71A | 6bniA-2j3mA:12.2 | 6bniA-2j3mA:8.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2o7q | BIFUNCTIONAL3-DEHYDROQUINATEDEHYDRATASE/SHIKIMATE DEHYDROGENASE (Arabidopsisthaliana) |
PF01487(DHquinase_I)PF01488(Shikimate_DH)PF08501(Shikimate_dh_N) | 5 | ASN A 483ARG A 488GLU A 491GLY A 465ILE A 496 | SO4 A1402 (-4.0A)NoneNoneNoneNone | 1.17A | 6bniA-2o7qA:undetectable | 6bniA-2o7qA:10.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2p4q | 6-PHOSPHOGLUCONATEDEHYDROGENASE,DECARBOXYLATING 1 (Saccharomycescerevisiae) |
PF00393(6PGD)PF03446(NAD_binding_2) | 5 | ASN A 387ARG A 342ALA A 335GLY A 337ILE A 357 | None | 1.19A | 6bniA-2p4qA:undetectable | 6bniA-2p4qA:11.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2p5k | ARGININE REPRESSOR (Bacillussubtilis) |
PF01316(Arg_repressor) | 5 | GLU A 47HIS A 7ALA A 39ARG A 6ILE A 10 | None | 1.24A | 6bniA-2p5kA:undetectable | 6bniA-2p5kA:21.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2p6p | GLYCOSYL TRANSFERASE (Streptomycesfradiae) |
PF06722(DUF1205) | 5 | PHE A 88ALA A 8GLU A 224GLY A 9ILE A 62 | None | 1.22A | 6bniA-2p6pA:undetectable | 6bniA-2p6pA:11.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qpx | PREDICTEDMETAL-DEPENDENTHYDROLASE OF THETIM-BARREL FOLD (Lactobacillusparacasei) |
PF04909(Amidohydro_2) | 5 | ARG A 298GLU A 302HIS A 268GLY A 292ILE A 285 | None | 1.17A | 6bniA-2qpxA:undetectable | 6bniA-2qpxA:13.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2v4i | GLUTAMATEN-ACETYLTRANSFERASE2 ALPHA CHAIN (Streptomycesclavuligerus) |
PF01960(ArgJ) | 5 | GLU A 59ALA A 50GLU A 85GLY A 51ILE A 108 | None | 1.19A | 6bniA-2v4iA:undetectable | 6bniA-2v4iA:13.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xgt | ASPARAGINYL-TRNASYNTHETASE,CYTOPLASMIC (Brugia malayi) |
PF00152(tRNA-synt_2)PF01336(tRNA_anti-codon) | 6 | ARG A 321GLU A 323HIS A 330GLY A 519ARG A 522ILE A 533 | NSS A1550 (-2.9A)NSS A1550 (-3.5A)NSS A1550 (-4.6A)NSS A1550 (-3.5A)NSS A1550 (-4.1A)None | 0.64A | 6bniA-2xgtA:30.6 | 6bniA-2xgtA:10.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xgt | ASPARAGINYL-TRNASYNTHETASE,CYTOPLASMIC (Brugia malayi) |
PF00152(tRNA-synt_2)PF01336(tRNA_anti-codon) | 6 | GLU A 323HIS A 330GLU A 471GLY A 519ARG A 522ILE A 533 | NSS A1550 (-3.5A)NSS A1550 (-4.6A) MG A1551 ( 2.6A)NSS A1550 (-3.5A)NSS A1550 (-4.1A)None | 0.70A | 6bniA-2xgtA:30.6 | 6bniA-2xgtA:10.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zr2 | SERYL-TRNASYNTHETASE (Pyrococcushorikoshii) |
PF00587(tRNA-synt_2b)PF02403(Seryl_tRNA_N) | 5 | ARG A 283GLU A 285PHE A 302ALA A 409GLU A 370 | AMP A1001 (-3.3A)AMP A1001 (-3.6A)AMP A1001 (-3.5A)AMP A1001 (-3.5A)AMP A1001 ( 3.2A) | 1.20A | 6bniA-2zr2A:10.2 | 6bniA-2zr2A:8.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zr2 | SERYL-TRNASYNTHETASE (Pyrococcushorikoshii) |
PF00587(tRNA-synt_2b)PF02403(Seryl_tRNA_N) | 5 | ARG A 283GLU A 285PHE A 302GLU A 370ARG A 412 | AMP A1001 (-3.3A)AMP A1001 (-3.6A)AMP A1001 (-3.5A)AMP A1001 ( 3.2A)SO4 A2005 ( 3.1A) | 0.78A | 6bniA-2zr2A:10.2 | 6bniA-2zr2A:8.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ztg | ALANYL-TRNASYNTHETASE (Archaeoglobusfulgidus) |
PF01411(tRNA-synt_2c)PF07973(tRNA_SAD) | 6 | ARG A 128HIS A 141PHE A 145GLU A 209GLY A 246ARG A 249 | A5A A 801 (-2.7A)A5A A 801 (-4.7A)A5A A 801 (-3.5A)A5A A 801 (-3.7A)A5A A 801 (-3.3A)A5A A 801 (-4.0A) | 0.71A | 6bniA-2ztgA:10.8 | 6bniA-2ztgA:7.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zzg | ALANYL-TRNASYNTHETASE (Pyrococcushorikoshii) |
PF01411(tRNA-synt_2c)PF07973(tRNA_SAD) | 6 | ARG A 128HIS A 141PHE A 145GLU A 210GLY A 252ARG A 255 | A5A A 999 (-3.0A)A5A A 999 (-4.8A)A5A A 999 (-3.4A)A5A A 999 (-3.4A)A5A A 999 (-3.2A)A5A A 999 (-3.7A) | 0.77A | 6bniA-2zzgA:10.8 | 6bniA-2zzgA:7.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3a74 | LYSYL-TRNASYNTHETASE (Geobacillusstearothermophilus) |
PF00152(tRNA-synt_2)PF01336(tRNA_anti-codon) | 7 | ARG A 253GLU A 255HIS A 261PHE A 265GLY A 467ARG A 470ILE A 481 | B4P A 494 ( 2.7A)B4P A 494 (-3.7A)B4P A 494 (-3.5A)B4P A 494 (-3.4A)B4P A 494 (-3.2A)B4P A 494 (-2.8A)None | 0.32A | 6bniA-3a74A:44.7 | 6bniA-3a74A:9.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3a74 | LYSYL-TRNASYNTHETASE (Geobacillusstearothermophilus) |
PF00152(tRNA-synt_2)PF01336(tRNA_anti-codon) | 5 | GLU A 255HIS A 261GLU A 411ARG A 470ILE A 481 | B4P A 494 (-3.7A)B4P A 494 (-3.5A)B4P A 494 (-3.4A)B4P A 494 (-2.8A)None | 1.16A | 6bniA-3a74A:44.7 | 6bniA-3a74A:9.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bn1 | PEROSAMINESYNTHETASE (Caulobactervibrioides) |
PF01041(DegT_DnrJ_EryC1) | 5 | ASN A 17GLU A 24ALA A 242GLY A 240ILE A 235 | None | 1.18A | 6bniA-3bn1A:undetectable | 6bniA-3bn1A:12.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3err | FUSION PROTEIN OFMICROTUBULE BINDINGDOMAIN FROM MOUSECYTOPLASMIC DYNEINAND SERYL-TRNASYNTHETASE FROMTHERMUS THERMOPHILUS (Mus musculus;Thermusthermophilus) |
PF00587(tRNA-synt_2b)PF12777(MT) | 6 | ARG A 256GLU A 258PHE A 275ALA A 383GLU A 345ARG A 386 | AMP A1507 (-3.1A)AMP A1507 (-3.5A)AMP A1507 (-3.8A)AMP A1507 ( 3.7A)AMP A1507 (-3.4A)AMP A1507 ( 4.0A) | 1.07A | 6bniA-3errA:5.4 | 6bniA-3errA:9.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3g1z | PUTATIVE LYSYL-TRNASYNTHETASE (Salmonellaenterica) |
PF00152(tRNA-synt_2) | 6 | ARG A 100GLU A 102HIS A 108ALA A 298GLU A 244ARG A 303 | AMP A 401 (-2.8A)AMP A 401 (-3.9A)PO4 A 326 (-3.7A)AMP A 401 (-3.8A)PO4 A 328 ( 2.8A)PO4 A 328 ( 2.4A) | 1.42A | 6bniA-3g1zA:32.3 | 6bniA-3g1zA:13.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3g1z | PUTATIVE LYSYL-TRNASYNTHETASE (Salmonellaenterica) |
PF00152(tRNA-synt_2) | 7 | ARG A 100GLU A 102HIS A 108PHE A 112GLU A 244GLY A 300ARG A 303 | AMP A 401 (-2.8A)AMP A 401 (-3.9A)PO4 A 326 (-3.7A)AMP A 401 (-3.5A)PO4 A 328 ( 2.8A)AMP A 401 (-3.5A)PO4 A 328 ( 2.4A) | 0.59A | 6bniA-3g1zA:32.3 | 6bniA-3g1zA:13.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hxw | ALANYL-TRNASYNTHETASE (Escherichiacoli) |
PF01411(tRNA-synt_2c) | 6 | ARG A 69HIS A 86PHE A 90GLU A 209GLY A 239ARG A 242 | SSA A 442 (-2.7A)NoneSSA A 442 (-3.5A)SSA A 442 (-3.9A)SSA A 442 (-3.5A)SSA A 442 (-3.8A) | 0.69A | 6bniA-3hxwA:13.4 | 6bniA-3hxwA:12.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3i7f | ASPARTYL-TRNASYNTHETASE (Entamoebahistolytica) |
PF00152(tRNA-synt_2)PF01336(tRNA_anti-codon) | 5 | HIS A 326GLU A 467GLY A 515ARG A 518ILE A 529 | None | 1.22A | 6bniA-3i7fA:26.5 | 6bniA-3i7fA:8.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3i7f | ASPARTYL-TRNASYNTHETASE (Entamoebahistolytica) |
PF00152(tRNA-synt_2)PF01336(tRNA_anti-codon) | 5 | HIS A 326PHE A 330GLU A 467GLY A 515ILE A 529 | None | 0.93A | 6bniA-3i7fA:26.5 | 6bniA-3i7fA:8.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3lss | SERYL-TRNASYNTHETASE (Trypanosomabrucei) |
PF00587(tRNA-synt_2b)PF02403(Seryl_tRNA_N) | 5 | ARG A 295GLU A 297PHE A 314ALA A 428GLU A 384 | ATP A 501 (-2.9A)ATP A 501 (-3.3A)ATP A 501 (-3.6A)ATP A 501 (-3.2A)ATP A 501 (-2.5A) | 1.22A | 6bniA-3lssA:10.4 | 6bniA-3lssA:11.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3lss | SERYL-TRNASYNTHETASE (Trypanosomabrucei) |
PF00587(tRNA-synt_2b)PF02403(Seryl_tRNA_N) | 5 | ARG A 295GLU A 297PHE A 314GLU A 384ARG A 431 | ATP A 501 (-2.9A)ATP A 501 (-3.3A)ATP A 501 (-3.6A)ATP A 501 (-2.5A)ATP A 501 (-3.9A) | 0.64A | 6bniA-3lssA:10.4 | 6bniA-3lssA:11.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3m4p | ASPARAGINYL-TRNASYNTHETASE, PUTATIVE (Entamoebahistolytica) |
PF00152(tRNA-synt_2)PF01336(tRNA_anti-codon) | 6 | ARG A 227GLU A 229HIS A 236GLY A 422ARG A 425ILE A 436 | 4AD A 500 (-3.1A)4AD A 500 (-4.2A)4AD A 500 (-4.5A)4AD A 500 (-3.7A)4AD A 500 (-3.8A)None | 0.65A | 6bniA-3m4pA:30.2 | 6bniA-3m4pA:10.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3m4p | ASPARAGINYL-TRNASYNTHETASE, PUTATIVE (Entamoebahistolytica) |
PF00152(tRNA-synt_2)PF01336(tRNA_anti-codon) | 6 | GLU A 229HIS A 236GLU A 374GLY A 422ARG A 425ILE A 436 | 4AD A 500 (-4.2A)4AD A 500 (-4.5A)4AD A 500 (-4.1A)4AD A 500 (-3.7A)4AD A 500 (-3.8A)None | 0.81A | 6bniA-3m4pA:30.2 | 6bniA-3m4pA:10.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3p8t | ASNS-LIKEASPARAGINYL-TRNASYNTHETASE RELATEDPROTEIN (Pyrococcusabyssi) |
PF00152(tRNA-synt_2) | 5 | ARG A 99GLU A 101HIS A 110GLU A 215ARG A 109 | None | 1.19A | 6bniA-3p8tA:28.0 | 6bniA-3p8tA:13.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3p8t | ASNS-LIKEASPARAGINYL-TRNASYNTHETASE RELATEDPROTEIN (Pyrococcusabyssi) |
PF00152(tRNA-synt_2) | 5 | ARG A 99GLU A 101PHE A 114ARG A 267ILE A 278 | None | 1.13A | 6bniA-3p8tA:28.0 | 6bniA-3p8tA:13.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3p8t | ASNS-LIKEASPARAGINYL-TRNASYNTHETASE RELATEDPROTEIN (Pyrococcusabyssi) |
PF00152(tRNA-synt_2) | 8 | ASN A 97ARG A 99GLU A 101HIS A 110PHE A 114GLU A 215GLY A 264ILE A 278 | None | 0.75A | 6bniA-3p8tA:28.0 | 6bniA-3p8tA:13.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3pco | PHENYLALANYL-TRNASYNTHETASE, ALPHASUBUNIT (Escherichiacoli) |
PF01409(tRNA-synt_2d)PF02912(Phe_tRNA-synt_N) | 6 | ARG A 195HIS A 202PHE A 206GLU A 268GLY A 298ARG A 301 | AMP A 992 (-4.0A)AMP A 992 (-3.6A)AMP A 992 (-3.5A)AMP A 992 (-3.8A)AMP A 992 ( 4.4A)AMP A 992 (-3.7A) | 0.80A | 6bniA-3pcoA:15.0 | 6bniA-3pcoA:11.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3teh | PHENYLALANYL-TRNASYNTHETASE ALPHACHAIN (Thermusthermophilus) |
PF01409(tRNA-synt_2d) | 5 | GLU A 206HIS A 212PHE A 216GLY A 318ILE A 332 | None | 0.86A | 6bniA-3tehA:5.3 | 6bniA-3tehA:10.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ufc | PUTATIVEUNCHARACTERIZEDPROTEIN (Pyrococcusfuriosus) |
PF01881(Cas_Cas6) | 5 | ASN X 124PHE X 126ALA X 216GLY X 219ILE X 132 | None | 1.11A | 6bniA-3ufcX:undetectable | 6bniA-3ufcX:14.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3w3s | TYPE-2 SERINE--TRNALIGASE (Methanopyruskandleri) |
PF00587(tRNA-synt_2b) | 5 | ARG A 349GLU A 351PHE A 364GLY A 482ARG A 485 | SSA A2002 (-3.0A)SSA A2002 (-3.2A)SSA A2002 ( 3.5A)SSA A2002 (-2.8A)SSA A2002 ( 3.7A) | 0.84A | 6bniA-3w3sA:9.8 | 6bniA-3w3sA:9.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wqy | ALANINE--TRNA LIGASE (Archaeoglobusfulgidus) |
PF01411(tRNA-synt_2c)PF02272(DHHA1)PF07973(tRNA_SAD) | 5 | ARG A 128HIS A 141PHE A 145GLY A 246ARG A 249 | A5A A1001 (-3.4A)A5A A1001 (-4.2A)A5A A1001 (-3.5A)A5A A1001 (-3.0A)A5A A1001 (-3.7A) | 0.77A | 6bniA-3wqyA:11.7 | 6bniA-3wqyA:6.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wqy | ALANINE--TRNA LIGASE (Archaeoglobusfulgidus) |
PF01411(tRNA-synt_2c)PF02272(DHHA1)PF07973(tRNA_SAD) | 5 | HIS A 141PHE A 145GLU A 209GLY A 246ARG A 249 | A5A A1001 (-4.2A)A5A A1001 (-3.5A)A5A A1001 (-3.8A)A5A A1001 (-3.0A)A5A A1001 (-3.7A) | 0.68A | 6bniA-3wqyA:11.7 | 6bniA-3wqyA:6.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4dpg | LYSINE--TRNA LIGASE (Homo sapiens) |
PF00152(tRNA-synt_2)PF01336(tRNA_anti-codon) | 6 | ARG A 323GLU A 325HIS A 331PHE A 335GLY A 550ILE A 564 | APC A 602 (-3.1A)APC A 602 ( 4.7A)APC A 602 (-4.2A)APC A 602 (-3.8A)APC A 602 (-3.4A)None | 0.89A | 6bniA-4dpgA:51.4 | 6bniA-4dpgA:9.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4dpg | LYSINE--TRNA LIGASE (Homo sapiens) |
PF00152(tRNA-synt_2)PF01336(tRNA_anti-codon) | 6 | ARG A 323PHE A 335GLU A 494GLY A 550ARG A 553ILE A 564 | APC A 602 (-3.1A)APC A 602 (-3.8A) MG A 603 ( 3.4A)APC A 602 (-3.4A)APC A 602 (-3.7A)None | 1.06A | 6bniA-4dpgA:51.4 | 6bniA-4dpgA:9.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4eo4 | THREONINE--TRNALIGASE,MITOCHONDRIAL (Saccharomycescerevisiae) |
PF00587(tRNA-synt_2b)PF03129(HGTP_anticodon) | 5 | ARG A 162GLU A 164PHE A 178GLY A 324ARG A 328 | SSA A1001 (-2.8A)SSA A1001 (-4.1A)SSA A1001 (-3.8A)SSA A1001 (-3.3A)SSA A1001 (-3.7A) | 0.69A | 6bniA-4eo4A:11.4 | 6bniA-4eo4A:11.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ex5 | LYSINE--TRNA LIGASE (Burkholderiathailandensis) |
PF00152(tRNA-synt_2)PF01336(tRNA_anti-codon) | 8 | ASN A 260ARG A 262GLU A 264PHE A 274GLU A 425GLY A 481ARG A 484ILE A 495 | NoneLYS A 601 (-3.7A)NoneNoneNoneNoneNoneNone | 0.67A | 6bniA-4ex5A:44.4 | 6bniA-4ex5A:10.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4h2x | AMINOACID--[ACYL-CARRIER-PROTEIN] LIGASE 1 (Agrobacteriumfabrum;Bradyrhizobiumdiazoefficiens) |
no annotation | 5 | ARG B 159GLU B 161PHE B 172GLY B 283ARG B 286 | G5A B 402 (-2.8A)G5A B 402 (-3.8A)G5A B 402 (-3.7A) CL B 403 ( 3.2A)G5A B 402 ( 3.8A) | 0.46A | 6bniA-4h2xB:11.1 | 6bniA-4h2xB:12.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4l87 | SERINE--TRNA LIGASE,CYTOPLASMIC (Homo sapiens) |
PF00587(tRNA-synt_2b)PF02403(Seryl_tRNA_N) | 5 | ARG A 302GLU A 304PHE A 321GLU A 391ARG A 435 | SSA A 501 (-2.4A)SSA A 501 (-3.4A)SSA A 501 (-3.5A) MG A 503 (-3.3A)SSA A 501 (-4.0A) | 0.89A | 6bniA-4l87A:10.3 | 6bniA-4l87A:10.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4lns | ASPARAGINESYNTHETASE A (Trypanosomabrucei) |
PF03590(AsnA) | 5 | HIS A 113GLU A 270GLY A 318ARG A 321ILE A 332 | None | 0.66A | 6bniA-4lnsA:20.9 | 6bniA-4lnsA:13.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4q6g | PYRROLYSINE--TRNALIGASE (Methanosarcinamazei) |
PF01409(tRNA-synt_2d) | 7 | ARG A 330GLU A 332HIS A 338GLU A 396GLY A 423ARG A 426ILE A 437 | ANP A 501 ( 3.2A)ANP A 501 (-4.0A)ANP A 501 (-3.9A)ANP A 501 (-3.2A)ANP A 501 (-3.5A)ANP A 501 (-2.7A)None | 0.91A | 6bniA-4q6gA:16.6 | 6bniA-4q6gA:10.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4q6g | PYRROLYSINE--TRNALIGASE (Methanosarcinamazei) |
PF01409(tRNA-synt_2d) | 7 | ARG A 330GLU A 332HIS A 338PHE A 342GLY A 423ARG A 426ILE A 437 | ANP A 501 ( 3.2A)ANP A 501 (-4.0A)ANP A 501 (-3.9A)ANP A 501 ( 3.6A)ANP A 501 (-3.5A)ANP A 501 (-2.7A)None | 0.76A | 6bniA-4q6gA:16.6 | 6bniA-4q6gA:10.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qei | GLYCINE--TRNA LIGASE (Homo sapiens) |
PF00587(tRNA-synt_2b)PF03129(HGTP_anticodon) | 5 | ARG A 277GLU A 279PHE A 292GLY A 526ARG A 529 | AMP A 701 (-2.9A)AMP A 701 (-4.3A)AMP A 701 (-3.6A)AMP A 701 (-3.2A)AMP A 701 (-4.1A) | 0.64A | 6bniA-4qeiA:11.8 | 6bniA-4qeiA:8.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4up7 | LYSINE--TRNA LIGASE (Entamoebahistolytica) |
PF00152(tRNA-synt_2)PF01336(tRNA_anti-codon) | 7 | ARG A 251GLU A 253HIS A 259PHE A 263GLY A 536ARG A 539ILE A 550 | LAD A1584 (-2.3A)LAD A1584 (-4.1A)LAD A1584 (-4.1A)LAD A1584 (-3.5A)LAD A1584 ( 3.7A)LAD A1584 (-4.1A)None | 0.35A | 6bniA-4up7A:48.3 | 6bniA-4up7A:6.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4up7 | LYSINE--TRNA LIGASE (Entamoebahistolytica) |
PF00152(tRNA-synt_2)PF01336(tRNA_anti-codon) | 5 | GLU A 253HIS A 259GLU A 480ARG A 539ILE A 550 | LAD A1584 (-4.1A)LAD A1584 (-4.1A)NoneLAD A1584 (-4.1A)None | 1.07A | 6bniA-4up7A:48.3 | 6bniA-4up7A:6.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4uzs | BETA-GALACTOSIDASE (Bifidobacteriumbifidum) |
PF02449(Glyco_hydro_42)PF08532(Glyco_hydro_42M)PF08533(Glyco_hydro_42C) | 5 | ASN A 27GLU A 368HIS A 371GLU A 320GLY A 24 | NoneGOL A 702 (-2.9A)NoneGOL A 702 (-2.7A)None | 1.11A | 6bniA-4uzsA:undetectable | 6bniA-4uzsA:8.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4wj3 | ASPARTATE--TRNA(ASP/ASN) LIGASE (Pseudomonasaeruginosa) |
PF00152(tRNA-synt_2)PF01336(tRNA_anti-codon)PF02938(GAD) | 5 | PHE M 232GLU M 483GLY M 535ARG M 538ILE M 549 | None | 1.13A | 6bniA-4wj3M:12.5 | 6bniA-4wj3M:8.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5e3i | HISTIDINE--TRNALIGASE (Acinetobacterbaumannii) |
PF03129(HGTP_anticodon)PF13393(tRNA-synt_His) | 5 | ARG A 115GLU A 117PHE A 127GLY A 313ARG A 316 | ATP A 501 ( 2.5A)ATP A 501 (-3.5A)ATP A 501 (-3.3A)ATP A 501 (-3.0A)ATP A 501 (-2.8A) | 0.50A | 6bniA-5e3iA:5.1 | 6bniA-5e3iA:11.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5eq6 | TYPE 4 FIMBRIALBIOGENESIS PROTEINPILM (Pseudomonasaeruginosa) |
PF11104(PilM_2) | 5 | ASN A 150ARG A 154ALA A 86GLU A 171GLY A 84 | NoneNoneNone MG A 402 ( 4.8A)None | 1.04A | 6bniA-5eq6A:undetectable | 6bniA-5eq6A:10.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hgq | LYSINE--TRNA LIGASE (Loa loa) |
PF00152(tRNA-synt_2)PF01336(tRNA_anti-codon) | 7 | ARG A 255GLU A 257HIS A 263PHE A 267GLU A 427GLY A 483ARG A 486 | LYS A 601 (-3.4A)KRS A 602 (-3.1A)KRS A 602 (-4.4A)KRS A 602 (-3.6A)KRS A 602 (-4.3A)KRS A 602 (-3.5A)KRS A 602 (-3.2A) | 0.80A | 6bniA-5hgqA:43.9 | 6bniA-5hgqA:8.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hgq | LYSINE--TRNA LIGASE (Loa loa) |
PF00152(tRNA-synt_2)PF01336(tRNA_anti-codon) | 7 | ARG A 255HIS A 263PHE A 267GLU A 427GLY A 483ARG A 486ILE A 497 | LYS A 601 (-3.4A)KRS A 602 (-4.4A)KRS A 602 (-3.6A)KRS A 602 (-4.3A)KRS A 602 (-3.5A)KRS A 602 (-3.2A)None | 0.38A | 6bniA-5hgqA:43.9 | 6bniA-5hgqA:8.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5j84 | DIHYDROXY-ACIDDEHYDRATASE (Rhizobiumleguminosarum) |
PF00920(ILVD_EDD) | 5 | ASN A 456HIS A 490ALA A 483GLY A 481ILE A 382 | None | 0.86A | 6bniA-5j84A:undetectable | 6bniA-5j84A:8.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5knn | ALANINE--TRNALIGASE, CYTOPLASMIC (Homo sapiens) |
PF01411(tRNA-synt_2c) | 6 | ARG A 77HIS A 94PHE A 98GLU A 213GLY A 243ARG A 246 | A5A A 500 (-2.8A)A5A A 500 (-4.5A)A5A A 500 (-3.4A)A5A A 500 (-3.8A)A5A A 500 (-3.4A)A5A A 500 (-3.9A) | 0.63A | 6bniA-5knnA:11.6 | 6bniA-5knnA:12.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5mgv | PHENYLALANINE--TRNALIGASE,MITOCHONDRIAL (Homo sapiens) |
PF01409(tRNA-synt_2d)PF03147(FDX-ACB) | 5 | ARG A 143HIS A 151PHE A 155GLY A 279ILE A 293 | None | 0.68A | 6bniA-5mgvA:14.3 | 6bniA-5mgvA:10.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vl1 | LYSINE--TRNA LIGASE (Mycobacteriumulcerans) |
PF00152(tRNA-synt_2)PF01336(tRNA_anti-codon) | 7 | ARG A 255GLU A 257HIS A 263PHE A 267GLY A 471ARG A 474ILE A 484 | LYS A 502 (-3.3A)NonePGE A 501 (-4.8A)PGE A 501 (-3.6A)PGE A 501 ( 4.4A)PGE A 501 (-3.6A)None | 0.77A | 6bniA-5vl1A:43.4 | 6bniA-5vl1A:10.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vl1 | LYSINE--TRNA LIGASE (Mycobacteriumulcerans) |
PF00152(tRNA-synt_2)PF01336(tRNA_anti-codon) | 5 | GLU A 257HIS A 263GLU A 415ARG A 474ILE A 484 | NonePGE A 501 (-4.8A)PGE A 501 (-4.1A)PGE A 501 (-3.6A)None | 0.93A | 6bniA-5vl1A:43.4 | 6bniA-5vl1A:10.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5zh5 | LYSINE--TRNA LIGASE (Plasmodiumfalciparum) |
no annotation | 6 | HIS A 338PHE A 342GLU A 500GLY A 556ARG A 559ILE A 570 | 9CX A 602 (-4.1A)9CX A 602 (-3.8A)9CX A 602 (-4.0A)9CX A 602 (-3.7A)9CX A 602 (-3.3A)9CX A 602 (-4.9A) | 0.40A | 6bniA-5zh5A:45.6 | 6bniA-5zh5A:33.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6aqh | LYSINE--TRNA LIGASE (Mycolicibacteriumthermoresistibile) |
PF00152(tRNA-synt_2)PF01336(tRNA_anti-codon) | 7 | ARG A 258HIS A 266PHE A 270GLU A 419GLY A 475ARG A 478ILE A 488 | LYS A 601 ( 3.4A)KRS A 602 (-4.5A)KRS A 602 (-3.5A)KRS A 602 (-3.8A)KRS A 602 (-3.8A)KRS A 602 (-3.5A)None | 0.53A | 6bniA-6aqhA:43.9 | 6bniA-6aqhA:10.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6blj | SERINE-TRNA LIGASE (Naegleriafowleri) |
no annotation | 5 | ARG A 306GLU A 308PHE A 325ALA A 439GLU A 398 | AMP A 500 (-3.0A)AMP A 500 (-3.4A)AMP A 500 (-3.6A)AMP A 500 (-3.4A)AMP A 500 (-3.2A) | 1.08A | 6bniA-6bljA:10.7 | 6bniA-6bljA:21.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6blj | SERINE-TRNA LIGASE (Naegleriafowleri) |
no annotation | 5 | ARG A 306GLU A 308PHE A 325GLU A 398ARG A 442 | AMP A 500 (-3.0A)AMP A 500 (-3.4A)AMP A 500 (-3.6A)AMP A 500 (-3.2A)AMP A 500 (-3.9A) | 0.49A | 6bniA-6bljA:10.7 | 6bniA-6bljA:21.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6chd | LYSINE--TRNA LIGASE (Homo sapiens) |
no annotation | 8 | ARG A 323GLU A 325HIS A 331PHE A 335GLU A 494GLY A 550ARG A 553ILE A 564 | KAA A 601 (-2.5A)KAA A 601 (-3.9A)KAA A 601 (-4.2A)KAA A 601 (-3.3A)KAA A 601 (-3.0A)KAA A 601 (-3.2A)KAA A 601 (-3.8A)None | 0.52A | 6bniA-6chdA:51.7 | 6bniA-6chdA:18.82 |